Common use of Reporting and Review Clause in Contracts

Reporting and Review. No later than [***] days following the conclusion of each Calendar Quarter during the Term and, additionally, upon [***] of a Product in the Field in the Territory, Maruho shall prepare and deliver to Evommune a written report summarizing: (a) all Development Activities conducted by or on behalf of Maruho in connection with the Product in the Field in the Territory during the preceding Calendar Quarter, (b) all Development Data and all other data and results arising the activities described in the foregoing (a), and (c) a written assessment of the results of such Development Activities (collectively the “Development Report”). Additionally, ▇▇▇▇▇▇ shall keep the JSC reasonably and regularly informed in connection with the preparation of all Regulatory Materials, Regulatory Authority review of Regulatory Materials, Regulatory Approvals, and Pricing Approvals, in each case with respect to each Product in the Field in the Territory. Maruho shall make appropriate personnel reasonably available to answer questions regarding the data and results described in the Development Report. ▇▇▇▇▇▇ acknowledges and agrees that Evommune shall have the right to keep Dermira and/or ▇▇▇▇▇ apprised of all Development and Commercialization efforts relating to any Product in the Field in the Territory to the extent required under the Dermira License, including that Evommune shall have the right to share the Development Report with ▇▇▇▇▇▇▇ and/or Lilly.

Reporting and Review. No later than [***] days following the conclusion of each Calendar Quarter during the Term and, additionally, upon [***] of a Product in the Field in the Territory, Maruho shall prepare and deliver to Evommune a written report summarizing: summarizing (a) all Development Activities conducted by or on behalf of Maruho in connection with the Product in the Field in the Territory during the preceding Calendar Quarter, (b) all Development Data and all other data and results arising the activities described in the foregoing (a), and (c) a written assessment of the results of such Development Activities (collectively Activities(collectively the “Development Report”). Additionally, ▇▇▇▇▇▇ shall keep the JSC reasonably and regularly informed in connection with the preparation of all Regulatory Materials, Regulatory Authority review of Regulatory Materials, Regulatory Approvals, and Pricing Approvals, in each case with respect to each Product in the Field in the Territory. Maruho shall make appropriate personnel reasonably available to answer questions regarding the data and results described in the Development Report. ▇▇▇▇▇▇ acknowledges and agrees that Evommune shall have the right to keep Dermira and/or ▇▇▇▇▇ apprised of all Development and Commercialization efforts relating to any Product in the Field in the Territory to the extent required under the Dermira License, including that Evommune shall have the right to share the Development Report with ▇▇▇▇▇▇▇ and/or Lilly.